Molecular Pathogenesis of Malignant Glial Tumors

Toxicologic Pathology

Volumn 39, Issue 1, 2011, Pages 158-166

  Jones, Terreia S ^a   Holland, Eric C ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

carcinogenesis; genetically engineered mice; molecular pathology

Indexed keywords

NOTCH RECEPTOR;

ANIMAL; ARTICLE; BRAIN TUMOR; CANCER STEM CELL; CENTRAL NERVOUS SYSTEM TUMOR; DISEASE MODEL; GENETICS; GLIOMA; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR PATHOLOGY; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DISEASE MODELS, ANIMAL; GLIOMA; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; PATHOLOGY, MOLECULAR; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 79959501464     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310387617     Document Type: Article

References (61)

1. Aghili M. Zahedi F. Rafiee E. (2009). Hydroxyglutaric aciduria and malignant brain tumor: A case report and literature review. J Neurooncol 91, 233–36.
2. Alcantara L. S. Chen J. Kwon C. H. Jackson E. L. Li Y. Burns D. K. Alvarez-Buylla A. Parada L. F. (2009). Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15, 45–56.
3. Bakshi A. Nag T. C. Wadhwa S. Mahapatra A. K. Sarkar C. (1998). The expression of nitric oxide synthases in human brain tumours and peritumoral areas. J Neurol Sci 155, 196–203.
4. Baron M. (2003). An overview of the Notch signalling pathway. Semin Cell Dev Biol 14, 113–19.
5. Bhattacharya S. Das A. Mallya K. Ahmad I. (2007). Maintenance of retinal stem cells by Abcg2 is regulated by notch signaling. J Cell Sci 120, 2652–62.
6. Bleau A. M. Hambardzumyan D. Ozawa T. Ozawa T. Fomchenko E. I. Huse J. T. Brennan C. W. Holland E. C. (2009). PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4, 226–35.
7. Brat D. J. Parisi J. E. Kleinschmidt-DeMasters B. K. Yachnis A. T. Montine T. J. Boyer P. J. Powell S. Z. Prayson R. A. McLendon R. E. (2008). Surgical neuropathology update: A review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med 132, 993–1007.
8. Brennan C. Momota H. Hambardzumyan D. Ozawa T. Tandon A. Pedraza A. Holland E. (2009). Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4, e7752.
9. Broholm H. Rubin I. Kruse A. Braendstrup O. Schmidt K. Skriver E. B. Lauritzen M. (2003). Nitric oxide synthase expression and enzymatic activity in human brain tumors. Clin Neuropathol 22, 273–81.
10. Calabrese C. Poppleton H. Kocak M. Hogg T. L. Fuller C. Hamner B. Oh E. Y. Gaber M. W. Finklestein D. Allen M. Frank A. Bayazitov I. T. Zakharenko S. S. Gajjar A. Davidoff A. Gilbertson R. J. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell 11, 69–82.
11. Cancer Genome Atlas Research Network (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–68.
12. Central Brain Tumor Registry of the United States (2010). CBTRUS 2010 Statistical Report: Primary Brain Tumors in the United States. Central Brain Tumor Registry of the United States, 2004-2006. http://www.cbtrus.org/2010-NPCR-SEER/CBTRUS-WEBREPORT-Final-3-2-10.pdf (accessed June 5, 2010).
13. Chakravarti A. Zhai G. Suzuki Y. Sarkesh S. Black P. M. Muzikansky A. Loeffler J. S. (2004). The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol 22, 1926–33.
14. Charles N. Ozawa T. Squatrito M. Bleau A. M. Brennan C. W. Hambardzumyan D. Holland E. C. (2010). Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6, 141–52.
15. Dai C. Celestino J. C. Okada Y. Louis D. N. Fuller G. N. Holland E. C. (2001). PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15, 1913–25.
16. Dang L. White D. W. Gross S. Bennett B. D. Bittinger M. A. Driggers E. M. Fantin V. R. Jang H. G. Jin S. Keenan M. C. Marks K. M. Prins R. M. Ward P. S. Yen K. E. Liau L. M. Rabinowitz J. D. Cantley L. C. Thompson C. B. Vander H. Heiden M. G. Su S. M. (2009). Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739–44.
17. Doetsch F (2003). A niche for adult neural stem cells. Curr Opin Genet Dev 13, 543–50.
18. Fan X. Matsui W. Khaki L. Stearns D. Chun J. Li Y. M. Eberhart C. G. (2006). Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 66, 7445–52.
19. Frederick L. Wang X. Y. Eley G. James C. D. (2000). Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res 60, 1383–87.
20. Fukumura D. Kashiwagi S. Jain R. K. (2006). The role of nitric oxide in tumour progression. Nat Rev Cancer 6, 521–34.
21. Furnari F. B. Fenton T. Bachoo R. M. Mukasa A. Stommel J. M. Stegh A. Hahn W. C. Ligon K. L. Louis D. N. Brennan C. Chin L. DePinho R. A. Cavenee W. K. (2007). Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 21, 2683–2710.
22. Gilbertson R. J. Rich J. N. (2007). Making a tumour’s bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7, 733–36.
23. Hambardzumyan D. Amankulor N. M. Helmy K. Y. Becher O. J. Holland E. C. (2009). Modeling adult gliomas using RCAS/t-va technology. Transl Oncol 2, 89–95.
24. Hambardzumyan D. Becher O. J. Rosenblum M. K. Pandolfi P. P. Manova-Todorova K. Holland E. C. (2008). PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev 22, 436–48.
25. Holland E. C. (2004). Mouse models of human cancer as tools in drug development. Cancer Cell 6, 197–98.
26. Hu X. Pandolfi P. P. Li Y. Koutcher J. A. Rosenblum M. Holland E. C. (2005). mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7, 356–68.
27. J.T., Huse, E.C., Holland, Genetically engineered mouse models of brain cancer and the promise of preclinical testing, Brain Pathol, (2009), 19, 132-143
28. Huse J. T. Holland E. C. (2010). Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10, 319–31.
29. Ignatova T. N. Kukekov V. G. Laywell E. D. Suslov O. N. Vrionis F. D. Steindler D. A. (2002). Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39, 193–206.
30. Knobbe C. B. Reifenberger G. (2003). Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3’-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13, 507–18.
31. Kolker S. Pawlak V. Ahlemeyer B. Okun J. G. Hörster F. Mayatepek E. Krieglstein J. Hoffmann G. F. Köhr G. (2002). NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria. Eur J Neurosci 16, 21–28.
32. Kwon C. H. Zhao D. Chen J. Alcantara S. Li Y. Burns D. K. Mason R. P. Lee E. Y. Wu H. Parada L. F. (2008). Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res 68, 3286–94.
33. Lim K. H. Ancrile B. B. Kashatus D. F. Counter C. M. (2008). Tumour maintenance is mediated by eNOS. Nature 452, 646–49.
34. Louis D. N. Ohgaki H. Wiestler O. D. Cavenee W. K. Burger P. C. Jouvet A. Scheithauer B. W. Kleihues P. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97–109.
35. Merchant T. E. Pollack I. F. Loeffler J. S. (2010). Brain tumors across the age spectrum: Biology, therapy, and late effects. Semin Radiat Oncol 20, 58–66.
36. Ohgaki H. Dessen P. Jourde B. Horstmann S. Nishikawa T. Di Patre P. L. Burkhard C. Schüler D. Probst-Hensch N. M. Maiorka P. C. Baeza N. Pisani P. Yonekawa Y. Yasargil M. G. Lütolf U. M. Kleihues P. (2004). Genetic pathways to glioblastoma: A population-based study. Cancer Res 64, 6892–99.
37. Parsons D. W. Jones S. Zhang X. Lin J. C. Leary R. J. Angenendt P. Mankoo P. Carter H. Siu I. M. Gallia G. L. Olivi A. McLendon R. Rasheed B. A. Keir S. Nikolskaya T. Nikolsky Y. Busam D. A. Tekleab H. Diaz L. A. Jr. Hartigan J. Smith D. R. Strausberg R. L. Marie S. K. Shinjo S. M. Yan H. Riggins G. J. Bigner D. D. Karchin R. Papadopoulos N. Parmigiani G. Vogelstein B. Velculescu V. E. Kinzler K. W. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–12.
38. Pfister S. Hartmann C. Korshunov A. (2009). Histology and molecular pathology of pediatric brain tumors. J Child Neurol 24, 1375–86.
39. Phillips H. S. Kharbanda S. Chen R. Forrest W. F. Soriano R. H. Wu T. D. Misra A. Nigro J. M. Colman H. Soroceanu L. Williams P. M. Modrusan Z. Feuerstein B. G. Aldape K. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157–73.
40. Ramirez-Castillejo C. Sanchez-Sanchez F. Andreu-Agullo C. Ferrón S. R. Aroca-Aguilar J. D. Sánchez P. Mira H. Escribano J. Fariñas I. (2006). Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci 9, 331–39.
41. Riquelme P. A. Drapeau E. Doetsch F. (2008). Brain micro-ecologies: Neural stem cell niches in the adult mammalian brain. Philos Trans R Soc Lond B Biol Sci 363, 123–37.
42. Shen Q. Goderie S. K. Jin L. Sun Y. Abramova N. Vincent P. Pumiglia K. Temple S. (2004). Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338–40.
43. Shen Q. Wang Y. Kokovay E. Lin G. Chuang S. M. Goderie S. K. Roysam B. Temple S. (2008). Adult SVZ stem cells lie in a vascular niche: A quantitative analysis of niche cell-cell interactions. Cell Stem Cell 3, 289–300.
44. Shete S. Hosking F. J. Robertson L. B. Dobbins S. E. Sanson M. Malmer B. Simon M. Marie Y. Boisselier B. Delattre J. Y. Hoang-Xuan K. El Hallani S. Idbaih A. Zelenika D. Andersson U. Henriksson R. Bergenheim A. T. Feychting M. Lönn S. Ahlbom A. Schramm J. Linnebank M. Hemminki K. Kumar R. Hepworth S. J. Price A. Armstrong G. Liu Y. Gu X. Yu R. Lau C. Schoemaker M. Muir K. Swerdlow A. Lathrop M. Bondy M. Houlston R. S. (2009). Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41, 899–904.
45. Shih A. H. Dai C. Hu X. Rosenblum M. K. Koutcher J. A. Holland E. C. (2004). Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 64, 4783–89.
46. Shih A. H. Holland E. C. (2006). Notch signaling enhances nestin expression in gliomas. Neoplasia 8, 1072–82.
47. Skeen J. E. Bhaskar P. T. Chen C. C. Chen W. S. Peng X. D. Nogueira V. Hahn-Windgassen A. Kiyokawa H. Hay N. (2006). Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell 10, 269–80.
48. Tada K. Shiraishi S. Kamiryo T. Nakamura H. Hirano H. Kuratsu J. Kochi M. Saya H. Ushio Y. (2001). Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: Correlation with patient age and survival. J Neurosurg 95, 651–59.
49. Uhrbom L. Dai C. Celestino J. C. Fuller G. N. Holland E. C. (2002). Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res 62, 5551–58.
50. Uhrbom L. Hesselager G. Nister M. Westermark B. (1998). Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res 58, 5275–79.
51. Verhaak R. G. Hoadley K. A. Purdom E. Wang V. Qi Y. Wilkerson M. D. Miller C. R. Ding L. Golub T. Mesirov J. P. Alexe G. Lawrence M. O’Kelly M. Tamayo P. Weir B. A. Gabriel S. Winckler W. Gupta S. Jakkula L. Feiler H. S. Hodgson J. G. James C. D. Sarkaria J. N. Brennan C. Kahn A. Spellman P. T. Wilson R. K. Speed T. P. Gray J. W. Meyerson M. Getz G. Perou C. M. Hayes D. N. and Cancer Genome Atlas Research Network (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98–110.
52. Wajner M. Kolker S. Souza D. O. Hoffmann G. F. de Mello C. F. (2004). Modulation of glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27, 825–28.
53. Wang B. Yang H. Huang Y. Z. Yan R. H. Liu F. J. Zhang J. N. (2010). Biologic characteristics of the side population of human small cell lung cancer cell line H446. Chin J Cancer 29, 254–60.
54. Wang Z. Li Y. Banerjee S. Sarkar F. H. (2008). Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res 28, 3621–30.
55. Wei Q. Clarke L. Scheidenhelm D. K. (2006). High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model. Cancer Res, 66, 7429–37.
56. Wen P. Y. Kesari S. (2008). Malignant gliomas in adults. N Engl J Med 359, 492–507.
57. Wrensch M. Jenkins R. B. Chang J. S. Yeh R. F. Xiao Y. Decker P. A. Ballman K. V. Berger M. Buckner J. C. Chang S. Giannini C. Halder C. Kollmeyer T. M. Kosel M. L. LaChance D. H. McCoy L. O’Neill B. P. Patoka J. Pico A. R. Prados M. Quesenberry C. Rice T. Rynearson A. L. Smirnov I. Tihan T. Wiemels J. Yang P. Wiencke J. K. (2009). Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41, 905–8.
58. Xiao A. Yin C. Yang C. Di Cristofano A. Pandolfi P. P. Van Dyke T. (2005). Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. Cancer Res 65, 5172–80.
59. Yanhong T. Lixin W. Huaiyin S. (forthcoming). Perivascular epithelioid cell tumor of the heart in a child. Pediatr Dev Pathol. doi: 10.2350/09-10-0726-CR.1.
60. Zhu H. Acquaviva J. Ramachandran P. Boskovitz A. Woolfenden S. Pfannl R. Bronson R. T. Chen J. W. Weissleder R. Housman D. E. Charest A. (2009). Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proc Natl Acad Sci U S A 106, 2712–16.
61. Zhu Y. Guignard F. Zhao D. Liu L. Burns D. K. Mason R. P. Messing A. Parada L. F. (2005). Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8, 119–30.